Slide Presentations: TCT 2017
Neurovascular Updates from TCT 2017
Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More
Does the presence of atrial septal aneurysm and/or a large degree of shunting identify patients most likely to benefit ? Yes !
Does the Presence of Atrial Septal Aneurysm and/or a Large Degree of Shunting Identify Patients Most Likely to Benefit? A: No!
Closure of Patent Foramen Ovale, Oral anticoagulants or Antiplatelet Therapy to Prevent Stroke Recurrence
What is the appropriate evaluation of cryptogenic stroke, and when is a hypercoagulability work-up needed?
Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? No!
Mortality after CABG vs PCI Individual Patient-Data Pooled Analysis of 11,518 Patients from 11 Randomized Trials
Shared Decision Making for PFO Closure: How to Make the FDA Requirements Work (and, are they requirements?)
How to Access and Treat Occluded Intracranial Arteries With Tortuous Anatomy and Rigid Skull Base Arteries
Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? Yes, the Data Are Clear!
Is Intervention for Asymptomatic Carotid Stenosis Indicated Given Modern Medical Management? No, the Data Are Clear!